Immunic Has Received A Notice Of Allowance From United States Patent And Trademark Office For Patent Covering Composition-Of-Matter Of Vidofludimus Calcium (IMU-838) And Related Production Method, Expected To Provide Protection Into 2039
Immunic已收到美国专利商标局批准的专利通知,该专利涵盖了Vidofludimus Calcium的物质成分和相关生产方法,预计将在2039年之前提供保护 IMU-838